U. Demirci Et Al. , "Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology," 50th Annual Meeting of the American-Society-of-Clinical-Oncology , vol.32, Illinois, United States Of America, 2014
Demirci, U. Et Al. 2014. Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology. 50th Annual Meeting of the American-Society-of-Clinical-Oncology , (Illinois, United States Of America).
Demirci, U., Oflazoglu, U., Kodaz, H., Ciltas, A., KEFELİ, U., Akyol, M., ... Ozturk, B.(2014). Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology . 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America
Demirci, Umut Et Al. "Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology," 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 2014
Demirci, Umut Et Al. "Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America, 2014
Demirci, U. Et Al. (2014) . "Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Umut Demirci Et Al. }, title={Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology}, congress name={50th Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Illinois}, country={United States Of America}, year={2014}}